The development of sophisticated animal models for human diseases often requires additional human keratinocyte-based cell culture models to reach valid conclusions regarding human disease mechanisms. The tissue culture models are increasingly relying on iPS technology to provide a potentially unlimited source of genetically -defined patient cells which can be turned into keratinocytes. These cells can then be used to establish skin equivalent in vitro as a model of human genodermatoses. Both animal design and the design of iPS-derived disease models increasingly require the ability to manipulate mammalian genes using new genome editing tools, such as zinc finger nucleases (ZFN), TALEN or the CRISPR/Cas system. Designing, generating, preserving and distributing sophisticated animal models that carry three or four different genetic elements or alleles often exceed the technical abilities of individual laboratories. Core facilities with an established track record of expert and reliable services are thus increasingly mission critical for the research program of our customer base. The proposed Bioengineering Core will enable researcher without prior experience in genetic engineering of mice to establish sophisticated animal models to study skin diseases. Further, using iPS cell technology, the proposed Bioengineering Core will support researchers in generating an unlimited resource of patient material, a prerequisite for establishing tissue culture-based models for human skin diseases. As in the past, we will continue to introduce new experimental tools to our research base to broaden and facilitate our research capabilities. Support from the SDRC will sustain this Core and enable SDRC researchers to receive continued discounted access to our services.

Public Health Relevance

The proposed services of the Bioengineering Core will enable our research base to continue with the design and generation of sophisticated animal models and human cell-based disease models. Access to the latest transgenic technology and consultations with respect to the latest genome editing tools will enable our customers to pursue new research avenues without delays caused by a lack resources and of expertise in Core-provided technologies

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR057212-06
Application #
8753459
Study Section
Special Emphasis Panel (ZAR1-KM (M1))
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
6
Fiscal Year
2014
Total Cost
$124,223
Indirect Cost
$44,101
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Mukherjee, Nabanita; Reuland, Steven N; Lu, Yan et al. (2015) Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol 135:842-50
O'Shea, Charlene; Fitzpatrick, James E; Koch, Peter J (2014) Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol 41:873-9
Luo, Yuchun; Cai, Xiangna; Liu, Sucai et al. (2014) Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A 111:15178-83
BarĂ³n, Anna E; Asdigian, Nancy L; Gonzalez, Victoria et al. (2014) Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes. Cancer Epidemiol Biomarkers Prev 23:2829-39
Koch, Peter J; Dinella, Jason; Fete, Mary et al. (2014) Modeling AEC-New approaches to study rare genetic disorders. Am J Med Genet A 164A:2443-54
Kogut, Igor; Roop, Dennis R; Bilousova, Ganna (2014) Differentiation of human induced pluripotent stem cells into a keratinocyte lineage. Methods Mol Biol 1195:1-12
Bilousova, Ganna; Roop, Dennis R (2014) Induced pluripotent stem cells in dermatology: potentials, advances, and limitations. Cold Spring Harb Perspect Med 4:a015164
Riemondy, Kent; Hoefert, Jaimee E; Yi, Rui (2014) Not miR-ly micromanagers: the functions and regulatory networks of microRNAs in mammalian skin. Wiley Interdiscip Rev RNA 5:849-65
Deng, Hui; Li, Fulun; Li, Hong et al. (2014) CtBP1 overexpression in keratinocytes perturbs skin homeostasis. J Invest Dermatol 134:1323-31
Dinella, Jason; Koster, Maranke I; Koch, Peter J (2014) Use of induced pluripotent stem cells in dermatological research. J Invest Dermatol 134:e23

Showing the most recent 10 out of 24 publications